AzTrials
AzTrials

Autism Spectrum DisorderMOTRICITE TSANCT05236803

Better Understand Motor Deficits Associated With Autism Spectrum Disorders: Development of an Assessment Protocol

A study testing Testing of general motor skills, fine motor skills and occulomotricity and Questionnaires in people with Autism Spectrum Disorder, run by Centre Hospitalier Charles Perrens, Bordeaux at 4 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This research is a case-control study aiming to characterize motor peculiarities (objective quantitative and qualitative measures) and its psycho-physiological correlates of children with ASD. Read more about this study

Who is it for?
Ages 6 to 11 yearsHealthy volunteers can take part
Conditions the study is for
Autism Spectrum Disorder
What is being tested?
Testing of general motor skills, fine motor skills and occulomotricity and Questionnaires
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
4 sitesFrance
Study dates
7 Feb 2022to 31 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 11 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • All participants :
  • Be between 6 and 11 years old
  • Mastery of the French language
  • Be affiliated with a Social Security scheme or benefit from affiliation by a third person
  • Both parents (or the holder of legal authority) have read, understood and signed the study consent
  • Be affiliated with social security
  • Participants with ASD should also verify the following inclusion criteria:
  • Being diagnosed with ASD (DSM-V)

Who cannot join

  • All participants :
  • Refusal to participate in the research on the part of the participant and / or holders of parental authority.
  • Be a person benefiting from enhanced protection, namely : persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social establishment.
  • Have uncorrected visual or hearing problems
  • To have concomitant psychotropic drug treatments not stabilized, initiated in the last 2 months: antipsychotics, mood stabilizers, anti-epileptics, psychostimulants, antidepressants.
  • Have a motor handicap of the upper or lower limbs, fitted or not.
Show all 10Show fewer
  • Have diagnosed neurological or psychiatric disorders, present a general or metabolic pathology having a known impact on the child's motor skills (eg: Epilepsy, Tics and Gilles de la Tourette Syndrome, Intellectual Deficiency, Neuromuscular Syndrome, Metabolic Neurological Syndrome , neoplasms)
  • Suspicion of low intellectual efficiency if at least one of the two subtests (Similarities or Matrices) of WISC V (retrieved from the medical file if the TSA participant) presents a result (standard score) strictly lower than 7.
  • Participants without ASD :
  • Participant with ADHD (Attention Deficit Disorder with or without Hyperactivity) or CDD (Developmental Coordination Disorder)

Trial locations and contacts

4 sites in 1 country. Contact the study team or a site near you to ask about taking part.

France4 sites, 4 recruiting
  • Centre Hospitalier Charles Perrens

    Bordeaux, 33076

    Anouck AMESTOY, MD, 05 56 56 67 19, aamestoy@ch-perrens.fr

    Recruiting
  • Centre Hospitalier La Rochelle Re Aunis

    La Rochelle, 17019

    Caroline ALLIX-BEGUEC, Ph.D., 05 16 49 42 46 ext. 54 246, caroline.allix-beguec@ght-atlantique17.fr

    Helene COTTENCEAU, MD

    Recruiting
  • CHU de LIMOGES

    Limoges, 87042

    Pascale DURET-BLANC, 05.55.05.89.87, pascale.duret-blanc@chu-limoges.fr

    Eric LEMONNIER, MD

    Recruiting
  • Centre Hospitalier Henri Laborit

    Poitiers, 86021

    Emilie VALIER-BRASIER, 05.49.44.57.59, emilie.valier-brasier@ch-poitiers.fr

    Jean XAVIER, MD

    Recruiting

Other trials in France

About this study

This research is a case-control study aiming to characterize motor peculiarities (objective quantitative and qualitative measures) and its psycho-physiological correlates of children with ASD.

Read the detailed description

The main objective is to measure jointly and in an automated and standardized manner the performance and motor patterns within the framework of tasks measuring the performance and patterns of general motor skills (postures, walking, coordination overall), fine motor skills (graphics, pointing task) and oculomotricity (visual orientation and control).

The secondary objective is to investigate the relationships between motor difficulties and cognitive and social disorders found in children with ASD.

  • Compare the motor performance data in the 3 major motor domains with each other (overall, fine and oculomotor);
  • Evaluate intergroup differences based on clinical characteristics (ADOS-2, ADI-R, CARS 2 scores), age, IQ, socio-communication profile score (SRS-2) and presence comorbidities (TADH, TDC).
Being tested
Testing of general motor skills, fine motor skills and occulomotricity, Questionnaires
Keywords
Autisme Spectrum Disorders, Motricity, Cognitive disorders, Behaviour, motor skill differences
Medical subject headings
Autism Spectrum Disorder, Cognitive Dysfunction, Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Testing of general motor skills, fine motor skills and occulomotricityBehavioural

    Recording of participant's performance during eye, fine motor and gross motor tests; Children's gross motor skills will be assessed through a biomechanical analysis.

    Eye movements will be recorded using the eye-tracking system (Tobii Pro TX300). The technique used is the corneal reflection technique.

  • QuestionnairesBehavioural

    Passing self and hetero questionnaires.

Study groups in NCT05236803
Study groupRoleWhat they receive
EpidemiologyOtherRecording of participant's performance during eye, fine motor and gross motor tests Passing self and hetero questionnaires.
Receives: Behavioral: Testing of general motor skills, fine motor skills and occulomotricity; Behavioral: Questionnaires

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measurement performance of fine motor skills (graphics, pointing task)

    Jointly and in an automated and standardized manner, measure performance in the context of tasks measuring the performance and patterns of general motor skills (postures, walking, overall coordination), fine motor skills (graphics, pointing task) and oculomotricity (visual orientation and control).

    Measured: At 3 month

  2. Measurement performance of general motor skills with biomechanical analysis

    Jointly and in an automated and standardized manner, measure motor patterns in the context of tasks measuring the performance and patterns of general motor skills (postures, walking, overall coordination), fine motor skills (graphics, pointing task) and oculomotricity (visual orientation and control).

    Measured: At 3 month

  3. Measurement of oculomotricity with eye-tracking system (visual orientation and control)

    Jointly and in an automated and standardized manner, motor patterns in the context of tasks measuring the performance and patterns of general motor skills (postures, walking, overall coordination), fine motor skills (graphics, pointing task) and oculomotricity (visual orientation and control).

    Measured: At 3 month

Secondary outcomes (7)
  1. Motor performance : success, error rate (%)

    Measured: At visit 1 and visit 2, an average of 3 months

  2. Motor performance : task duration (ms), reaction time (ms) and latency (ms)

    Measured: At visit 1 and visit 2, an average of 3 months

  3. IQ as assessed using WISC IV

    Measured: At visit 1 and visit 2, an average of 3 months

  4. Score of socio-communicative skills as assessed using Social Responsiveness Scale

    Social Responsiveness Scale :

    Min = 30, Max=90 Higher scores mean a worse outcome

    Measured: At visit 1 and visit 2, an average of 3 months

  5. ADHD as assessed using Conners-3

    Measured: At visit 1 and visit 2, an average of 3 months

  6. Developmental Coordination Disorder as assessed using Developmental Coordination Disorder Questionnaire

    Developmental Coordination Disorder Questionnaire :

    Min = 15, Max = 75 Higher scores mean a better outcome

    Measured: At visit 1 and visit 2, an average of 3 months

  7. ASD Clinical Assessment as assessed using Childhood Autism Rating Scale

    Childhood Autism Rating Scale :

    Min = 0, Max = 100 Higher scores mean a worse outcome

    Measured: At visit 1 and visit 2, an average of 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Feb 2022
  2. Study start7 Feb 2022
  3. Primary completion30 Oct 2026 (estimated)
  4. Study completion31 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
110 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05236803
Sponsor's protocol ID
2021-A02426-35
Acronym
MOTRICITE TSA
Status last verified
Mar 2026
First submitted
15 Dec 2021
Last updated
16 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Biffi E, Costantini C, Ceccarelli SB, Cesareo A, Marzocchi GM, Nobile M, Molteni M, Crippa A. Gait Pattern and Motor Performance During Discrete Gait Perturbation in Children With Autism Spectrum Disorders. Front Psychol. 2018 Dec 11;9:2530. doi: 10.3389/fpsyg.2018.02530. eCollection 2018.

    PubMed 30618953
  • Cazalets JR, Bestaven E, Doat E, Baudier MP, Gallot C, Amestoy A, Bouvard M, Guillaud E, Guillain I, Grech E, Van-Gils J, Fergelot P, Fraisse S, Taupiac E, Arveiler B, Lacombe D. Evaluation of Motor Skills in Children with Rubinstein-Taybi Syndrome. J Autism Dev Disord. 2017 Nov;47(11):3321-3332. doi: 10.1007/s10803-017-3259-1.

    PubMed 28748333
  • D'Mello AM, Stoodley CJ. Cerebro-cerebellar circuits in autism spectrum disorder. Front Neurosci. 2015 Nov 5;9:408. doi: 10.3389/fnins.2015.00408. eCollection 2015.

    PubMed 26594140
  • Eggleston JD, Harry JR, Cereceres PA, Olivas AN, Chavez EA, Boyle JB, Dufek JS. Lesser magnitudes of lower extremity variability during terminal swing characterizes walking patterns in children with autism. Clin Biomech (Bristol). 2020 Jun;76:105031. doi: 10.1016/j.clinbiomech.2020.105031. Epub 2020 May 7.

    PubMed 32408186
  • Hak L, Houdijk H, Beek PJ, van Dieen JH. Steps to take to enhance gait stability: the effect of stride frequency, stride length, and walking speed on local dynamic stability and margins of stability. PLoS One. 2013 Dec 13;8(12):e82842. doi: 10.1371/journal.pone.0082842. eCollection 2013.

    PubMed 24349379

Questions about this trial

What is this clinical trial studying?

A study testing Testing of general motor skills, fine motor skills and occulomotricity and Questionnaires in people with Autism Spectrum Disorder, run by Centre Hospitalier Charles Perrens, Bordeaux at 4 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Anouck AMESTOY, MD (05 56 56 67 19, aamestoy@ch-perrens.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measurement performance of fine motor skills (graphics, pointing task) (time frame: At 3 month). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05236803, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in